When you stop taking Mounjaro (tirzepatide), its appetite-suppressing effects fade over the following weeks, hunger and food noise tend to return, and many people regain some — sometimes much — of the weight they lost unless they have a strong maintenance plan in place. Mounjaro manages weight while you take it; it does not permanently reset your appetite, so stopping is best planned carefully with your prescriber rather than abruptly.
Why stopping changes how you feel
Mounjaro works by activating two gut-hormone receptors, GLP-1 and GIP, at the same time. These signals make you feel fuller sooner, keep you satisfied for longer, and slow how quickly your stomach empties.
Those effects depend on the medicine being in your body. Tirzepatide is a once-weekly injection, so once you stop, the drug clears over several weeks and the appetite signals it was providing gradually disappear.
The result is often described as the return of "food noise" — thoughts about food, stronger hunger between meals, and larger portions feeling normal again. This is a physiological response, not a lack of willpower.
Appetite rebound: what to expect
As the medicine leaves your system, your appetite typically returns towards its pre-treatment level. Some people notice this within a week or two; for others it builds over a month.
Importantly, obesity is a long-term, relapsing condition. The underlying biology that made weight gain easier for you in the first place does not go away just because you lost weight — which is why appetite often rebounds strongly once treatment stops.
Understanding this in advance helps you prepare, rather than feeling blindsided when hunger increases.
Weight regain: the honest picture
Clinical evidence across the GLP-1 and dual-agonist class consistently shows that a meaningful proportion of lost weight tends to return after the medicine is stopped, particularly where lifestyle habits have not been firmly established.
This does not mean the weight you lost was "fake" or that treatment failed. It reflects the fact that these medicines treat an ongoing condition — much like blood-pressure medication, blood pressure tends to rise again if the treatment stops.
To stay within the facts: in the SURMOUNT-1 trial, participants on the 15mg dose lost on average 22.5% of body weight over 72 weeks, alongside lifestyle support. Individual results vary; not everyone reaches this. Those results were achieved while taking the medicine and with lifestyle changes — the figure describes treatment, not what happens after stopping.
Reasons people stop — and why the plan matters
- Reaching a goal weight and wanting to maintain without medication.
- Side effects — common ones include nausea, diarrhoea, constipation, vomiting, decreased appetite and fatigue.
- Cost, supply, or life circumstances such as planning a pregnancy (Mounjaro is not suitable if you are pregnant, planning pregnancy or breastfeeding).
- Clinical advice from your prescriber.
Whatever the reason, the safest approach is to discuss it with a GPhC-registered prescriber rather than stopping on your own. You can raise any of this through our team via contact us or a review consultation.
How to stop: taper or stop outright?
There is no fixed "withdrawal" syndrome with tirzepatide in the way there is with some medicines, but how you stop can affect how manageable the transition feels.
Some prescribers suggest stepping down through the dose levels — for example from 15mg towards 12.5mg, 10mg and below — rather than stopping from a high dose in one go, to make the return of appetite more gradual and easier to manage with habits. Mounjaro doses are £295 (15mg), £275 (12.5mg), £260 (10mg), £240 (7.5mg), £185 (5mg) and £160 (2.5mg) per month.
Any change to your dose or stopping plan should be agreed with your prescriber, who can tailor it to your situation. Never adjust the dose yourself.
Building a maintenance plan
The single biggest factor in keeping weight off after stopping is having genuinely embedded habits long before your last dose. Use your time on treatment — when appetite is easier to manage — to build routines that can stand on their own.
Protein and fullness
Prioritising protein at each meal supports fullness and helps protect muscle, which matters because muscle keeps your metabolism higher. Build meals around a protein source first, then vegetables and fibre.
Strength and movement
Resistance training two to three times a week helps preserve the muscle you have, while regular daily movement supports overall energy balance. Muscle lost during rapid weight loss is hard to regain, so protecting it is a priority.
Routines, not restriction
Regular meal timing, planning ahead, managing sleep and stress, and watching portion sizes all help counter the return of appetite. Weighing yourself regularly lets you catch small regains early, while they are easy to reverse.
Ongoing clinical support
Structured follow-up makes a real difference. A prescriber-led service can help you plan a step-down, review progress, and decide whether continuing, pausing, or switching treatment is right for you.
Could continuing, or switching, be appropriate?
For some people, obesity is best managed with longer-term treatment rather than a short course, in the same way other long-term conditions are. This is a clinical decision — not something to assume or decide alone.
If side effects or cost are the reason you want to stop, it may be worth discussing alternatives with your prescriber. Other options include the Wegovy injection, the once-daily Wegovy Tablet, and Foundayo (orforglipron), a once-daily tablet. You can compare these on our treatments overview and weight-loss injections pages. There is no fixed dose equivalence between these medicines, so any switch starts with a fresh clinical assessment and an appropriate starting dose.
Reporting side effects
Serious but rare effects can include severe allergic reaction, acute pancreatitis, severe hypoglycaemia, severe gastrointestinal disease and worsening diabetic retinopathy. If you experience a side effect, you can report it via the MHRA Yellow Card scheme at https://yellowcard.mhra.gov.uk/.
The bottom line
Stopping Mounjaro usually brings appetite back and carries a real risk of weight regain — but regain is not inevitable. The people who maintain their results best are those who used their time on treatment to build durable habits and planned their next step with a prescriber.
If you are thinking about starting, stopping or switching, a free online consultation with our GPhC-registered prescribers is the safest place to start. You can also learn more about The Weight Clinic or read more guides on our blog. Mounjaro and all weight-management medicines are prescription-only and are provided only if clinically appropriate — a prescription is never guaranteed.
This article is for information only and is not a substitute for personalised medical advice. Weight-loss medicines are prescription-only, are not suitable for everyone, and are prescribed only after a clinical consultation with a GPhC-registered prescriber. Individual results vary. Always speak to a UK-registered pharmacist or doctor before starting or changing any prescription medication.
